Scott Johnstone, Chief Executive of the Scvottish Lifesciences Association, said "We welcome today's news that Borders-based ProStrakan has agreed to acquire Archimedes Pharma. This is further evidence of Scotland's ability to develop globally successful life sciences businesses, and of the growing importance of this vibrant sector to the Scottish economy. The track record of Scottish life sciences companies developing and offering innovative products and therapies speaks for itself, and we congratulate ProStrakan – and Archimedes – on this deal."
11 July 2014